Round Rock Advisors’s Novartis NVS Stock Holding History

Round Rock Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,750	Closed	-$241K	–	345
2025 Q4	$241K	Hold	1,750	–	–	0.04%	305
2025 Q3	$224K	Sell	1,750 -3,500	-67%	-$427K	0.04%	297
2025 Q2	$635K	Buy	5,250 +1,500	+40%	+$169K	0.11%	121
2025 Q1	$418K	Hold	3,750	–	–	0.08%	144
2024 Q4	$365K	Buy	3,750 +250	+7%	+$26.7K	0.07%	150
2024 Q3	$403K	Hold	3,500	–	–	0.09%	123
2024 Q2	$373K	Hold	3,500	–	–	0.09%	128
2024 Q1	$339K	Hold	3,500	–	–	0.08%	148
2023 Q4	$353K	Sell	3,500 -85	-2%	-$8.21K	0.09%	136
2023 Q3	$365K	Hold	3,585	–	–	0.14%	101
2023 Q2	$362K	Hold	3,585	–	–	0.13%	104
2023 Q1	$330K	Buy	3,585 +85	+2%	+$7.42K	0.13%	106
2022 Q4	$318K	Hold	3,500	–	–	0.13%	109
2022 Q3	$266K	Hold	3,500	–	–	0.12%	116
2022 Q2	$296K	Buy	3,500 +540	+18%	+$47.4K	0.13%	104
2022 Q1	$260K	Buy	+2,960	New	+$256K	0.11%	118

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Round Rock Advisors's NVS Position: Q1 2026 in Review

Round Rock Advisors sold out of Novartis (NVS) in Q1 2026, closing a stake of 1,750 shares — an estimated $241K sold.

Round Rock Advisors first reported a position in NVS in Q1 2022 and held it in 16 quarters. The position peaked at $635K in Q2 2025. 1,605 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Round Rock Advisors reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
Round Rock Advisors sold 1,750 Novartis shares in Q1 2026, an estimated $241K.
Round Rock Advisors first reported a position in Novartis in Q1 2022 and held it in 16 quarters.
Round Rock Advisors's Novartis position peaked at $635K in Q2 2025.
1,605 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Round Rock Advisors's 13F filing for Q1 2026, filed 15 May 2026.